AB817: Bill Text

AB817, s. 179 Section 179. 161.17 (title) of the statutes is renumbered 961.17 (title).

AB817, s. 180 Section 180. 161.17 of the statutes is renumbered 961.17 (1m), and 961.17 (1m) (intro.) and (a), as renumbered, are amended to read:

AB817,57,14 961.17 (1m) (intro.) The controlled substances board shall place add a substance in to schedule III if it finds upon finding that:

AB817,57,16 (a) The substance has a potential for abuse less than the substances listed included in schedules I and II;

AB817, s. 181 Section 181. 161.18 (title) of the statutes is renumbered 961.18 (title).

AB817, s. 182 Section 182. 161.18 (1) (title) of the statutes is repealed.

AB817, s. 183 Section 183. 161.18 (1) of the statutes is renumbered 961.18 (intro.) and amended to read:

AB817,57,23 961.18 (intro.) The Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in this section are included in schedule III.:

AB817, s. 184 Section 184. 161.18 (2m) of the statutes is renumbered 961.18 (2m), and 961.18 (2m) (intro.), as renumbered, is amended to read:

AB817,58,6 961.18 (2m) Stimulants. (intro.) Unless specifically excepted by federal regulations or unless listed in another schedule, any Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist that are theoretically possible within the specific chemical designation:

AB817, s. 185 Section 185. 161.18 (3) (intro.) of the statutes is renumbered 961.18 (3) (intro.) and amended to read:

AB817,58,14 961.18 (3) Depressants. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist that are theoretically possible within the specific chemical designation:

AB817, s. 186 Section 186. 161.18 (3) (a) of the statutes is renumbered 961.18 (3) (a) and amended to read:

AB817,58,19 961.18 (3) (a) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules;

AB817, s. 187 Section 187. 161.18 (3) (b) of the statutes is renumbered 961.18 (3) (b).

AB817, s. 188 Section 188. 161.18 (3) (d) of the statutes is renumbered 961.18 (3) (d).

AB817, s. 189 Section 189. 161.18 (3) (e) of the statutes is renumbered 961.18 (3) (e).

AB817, s. 190 Section 190. 161.18 (3) (f) of the statutes is renumbered 961.18 (3) (f).

AB817, s. 191 Section 191. 161.18 (3) (h) of the statutes is renumbered 961.18 (3) (h).

AB817, s. 192 Section 192. 161.18 (3) (j) of the statutes is renumbered 961.18 (3) (j).

AB817, s. 193 Section 193. 161.18 (3) (k) of the statutes is renumbered 961.18 (3) (k) and amended to read:

AB817,59,3 961.18 (3) (k) Sulfonmethane.;

AB817, s. 194 Section 194. 161.18 (3) (km) of the statutes is renumbered 961.18 (3) (km) and amended to read:

AB817,59,6 961.18 (3) (km) Tiletamine and Zolazepam or any salt thereof in combination;

AB817, s. 195 Section 195. 161.18 (3) (m) of the statutes is renumbered 961.18 (3) (m) (intro.) and amended to read:

AB817,59,11 961.18 (3) (m) (intro.) Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital any of the following drugs and one or more other active medicinal ingredients which are not listed included in any schedule. :

AB817, s. 196 Section 196. 161.18 (3) (n) of the statutes is renumbered 961.18 (3) (n) (intro.) and amended to read:

AB817,59,16 961.18 (3) (n) (intro.) Any of the following drugs in suppository dosage form containing amobarbital, secobarbital or pentobarbital and approved by the federal food and drug administration for marketing only as a suppository.:

AB817, s. 197 Section 197. 161.18 (4) of the statutes is renumbered 961.18 (4), and 961.18 (4) (intro.), as renumbered, is amended to read:

AB817,59,24 961.18 (4) Other substances. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of the following substances or, including any of their salts, isomers or and salts of isomers , if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation:

AB817, s. 198 Section 198. 161.18 (5) of the statutes is renumbered 961.18 (5), and 961.18 (5) (intro.), (a), (b), (c), (d), (e) and (f), as renumbered, are amended to read:

AB817,60,7 961.18 (5) Narcotic drugs. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation containing any of the following narcotic drugs or their salts, isomers or salts of isomers, calculated as the free anhydrous base or alkaloid, in the following specified limited quantities as follows:

AB817,60,10 (a) Not more than 1.8 grams of codeine per 100 milliliters or per 100 grams or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;.

AB817,60,13 (b) Not more than 1.8 grams of codeine per 100 milliliters or per 100 grams or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;.

AB817,60,16 (c) Not more than 300 milligrams of hydrocodone per 100 milliliters or per 100 grams or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium;.

AB817,60,19 (d) Not more than 300 milligrams of hydrocodone per 100 milliliters or per 100 grams or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; .

AB817,60,22 (e) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or per 100 grams or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; .

AB817,60,25 (f) Not more than 300 milligrams of ethylmorphine per 100 milliliters or per 100 grams or not more than 15 milligrams per dosage unit, with one or more ingredients in recognized therapeutic amounts;.

AB817, s. 199 Section 199. 161.18 (6) of the statutes is renumbered 961.18 (6) and amended to read:

AB817,61,11 961.18 (6) Exceptions. The controlled substances board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed included in sub. (2m) or (3) from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

AB817, s. 200 Section 200. 161.18 (7) of the statutes is renumbered 961.18 (7), and 961.18 (7) (intro.), as renumbered, is amended to read:

AB817,61,19 961.18 (7) (title) Anabolic Steroids steroids. (intro.) Any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroids, including any of their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, whenever those esters, isomers, esters of isomers, salts and salts, esters, isomers and esters of isomers exist that are theoretically possible within the specific chemical designation:

AB817, s. 201 Section 201. 161.19 (title) of the statutes is renumbered 961.19 (title).

AB817, s. 202 Section 202. 161.19 of the statutes is renumbered 961.19 (1m), and 961.19 (1m) (intro.), (a) and (c), as renumbered, are amended to read:

AB817,61,24 961.19 (1m) (intro.) The controlled substances board shall place add a substance in to schedule IV if it finds upon finding that:

AB817,62,2 (a) The substance has a low potential for abuse relative to substances included in schedule III;

AB817,62,4 (c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.

AB817, s. 203 Section 203. 161.20 (title) of the statutes is renumbered 961.20 (title).

AB817, s. 204 Section 204. 161.20 (1) (title) of the statutes is repealed.

AB817, s. 205 Section 205. 161.20 (1) of the statutes is renumbered 961.20 (intro.) and amended to read:

AB817,62,11 961.20 (intro.) The Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in this section are included in schedule IV.:

AB817, s. 206 Section 206. 161.20 (2) of the statutes is renumbered 961.20 (2), and 961.20 (2) (intro.) and (h), as renumbered, are amended to read:

AB817,62,19 961.20 (2) Depressants. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation:

AB817,62,20 (h) Methylphenobarbital, which is also called mephobarbital;

AB817, s. 207 Section 207. 161.20 (2m) (intro.) of the statutes is renumbered 961.20 (2m) (intro.) and amended to read:

AB817,63,3 961.20 (2m) Stimulants. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation:

AB817, s. 208 Section 208. 161.20 (2m) (a) of the statutes is renumbered 961.20 (2m) (a).

AB817, s. 209 Section 209. 161.20 (2m) (ag) of the statutes is renumbered 961.20 (2m) (ag) and amended to read:

AB817,63,8 961.20 (2m) (ag) N,N-dimethyl-1-1,2-diphenylethylamine N,N-dimethyl-1,2-diphenylethylamine, commonly known as "SPA";.

AB817, s. 210 Section 210. 161.20 (2m) (ar) of the statutes is renumbered 961.20 (2m) (ar) and amended to read:

AB817,63,11 961.20 (2m) (ar) Fencamfamine;.

AB817, s. 211 Section 211. 161.20 (2m) (b) of the statutes is renumbered 961.20 (4) (am) and amended to read:

AB817,63,14 961.20 (4) (am) Fenfluramine, including any of its isomers and salts of isomers.

AB817, s. 212 Section 212. 161.20 (2m) (bm) of the statutes is renumbered 961.20 (2m) (bm) and amended to read:

AB817,63,17 961.20 (2m) (bm) Mazindol;.

AB817, s. 213 Section 213. 161.20 (2m) (c) of the statutes is renumbered 961.20 (2m) (c) and amended to read:

AB817,63,20 961.20 (2m) (c) Pemoline, including its organometallic complexes and chelates.

AB817, s. 214 Section 214. 161.20 (2m) (d) of the statutes is renumbered 961.20 (2m) (d).

AB817, s. 215 Section 215. 161.20 (2m) (e) of the statutes is renumbered 961.20 (2m) (e).

AB817, s. 216 Section 216. 161.20 (3) of the statutes is renumbered 961.20 (3), and 961.20 (3) (intro.), as renumbered, is amended to read:

AB817,64,8 961.20 (3) Narcotic drugs containing nonnarcotic active medicinal ingredients. (intro.) Any compound, mixture or preparation containing limited quantities of any of the following narcotic drugs or their salts, isomers or salts of isomers, in limited quantities as set forth below, calculated as the free anhydrous base or alkaloid, which also contains one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

AB817, s. 217 Section 217. 161.20 (3m) (title) of the statutes is repealed.

AB817, s. 218 Section 218. 161.20 (3m) of the statutes is renumbered 961.20 (2m) (ak) and amended to read:

AB817,64,18 961.20 (2m) (ak) Unless specifically excepted under federal regulations or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of ephedrine or a salt of ephedrine, an optical isomer of ephedrine or a salt of an optical isomer of ephedrine. This subsection applies only Ephedrine, if the ephedrine, salt, optical isomer or salt of the optical isomer is the only active medicinal ingredient or if there are only therapeutically insignificant quantities of another active medicinal ingredient.

AB817, s. 219 Section 219. 161.20 (4) of the statutes is renumbered 961.20 (4), and 961.20 (4) (intro.) and (b), as renumbered, are amended to read:

AB817,64,24 961.20 (4) Other substances. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:

AB817,64,25 (b) Pentazocine, including any of its isomers and salts of isomers.

AB817, s. 220 Section 220. 161.20 (5) of the statutes is renumbered 961.20 (5) and amended to read:

AB817,65,10 961.20 (5) Exceptions. The controlled substances board may except by rule any compound, mixture or preparation containing any depressant substance listed included in sub. (2) from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

AB817, s. 221 Section 221. 161.21 (title) of the statutes is renumbered 961.21 (title).

AB817, s. 222 Section 222. 161.21 of the statutes is renumbered 961.21 (1m), and 961.21 (1m) (intro.), (a) and (c), as renumbered, are amended to read:

AB817,65,15 961.21 (1m) (intro.) The controlled substances board shall place add a substance in to schedule V if it finds upon finding that:

AB817,65,17 (a) The substance has low potential for abuse relative to the controlled substances listed included in schedule IV;

AB817,65,20 (c) The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed included in schedule IV.

AB817, s. 223 Section 223. 161.22 (title) of the statutes is renumbered 961.22 (title).

AB817, s. 224 Section 224. 161.22 (1) (title) of the statutes is repealed.

AB817, s. 225 Section 225. 161.22 (1) of the statutes is renumbered 961.22 (intro.) and amended to read:

AB817,66,3 961.22 (intro.) The Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in this section are included in schedule V.:

AB817, s. 226 Section 226. 161.22 (1m) of the statutes is renumbered 961.22 (1m), and 961.22 (1m) (intro.), as renumbered, is amended to read: